David M. Polen
Polen Capital Management
Polen Capital Management Progyny Inc stake
total: 588
Polen Capital Management PGNY trades
- Total transactions:
- 19
- New positions:
- 1
- Sold out:
- 1
- Added:
- 8
- Reduced:
- 9
- Held since:
- 2021 Q1
- Held for:
- 18 quarters
- Latest activity:
- 2025 Q3
According to 2026 Q2 report, Polen Capital Management doesn't hold any Progyny Inc (PGNY) shares. To date, the estimated cost basis is nearly $44.32 for "buy" trades and estimated average "sell" price is $24.67. Polen Capital Management first purchased PGNY in 2021 Q1, initially acquiring 221,805 shares. Since the initial investment in Progyny Inc (PGNY), Polen Capital Management has made 18 more transactions.
When did Polen Capital Management sell Progyny Inc (PGNY)?
Polen Capital Management sold off the entire Progyny Inc (PGNY) position in 2025 Q3.
When did Polen Capital Management buy Progyny Inc (PGNY)?
Polen Capital Management first invested in Progyny Inc (PGNY) in 2021 Q1 at the reported quarter-end price of $44.51 per share.
What's the cost basis of Polen Capital Management's PGNY stake?
The estimated cost basis for Progyny Inc (PGNY) stake is around $44.32 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $44.32
- Weighted AVG sell price:
- $24.67
Polen Capital Management's historical trades in Progyny Inc
19 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.00%
|
0
|
$22.00
|
|
-100% (-64,650)
|
-0%
|
|
2025 Q2
|
0.00%
|
64,650
|
$22.00
|
$1,422,300
|
-75.28% (-196,856)
|
-0.01%
|
|
2025 Q1
|
0.02%
|
261,506
|
$22.34
|
$5,842,046
|
+0.31% (+798)
|
+0%
|
|
2024 Q4
|
0.01%
|
260,708
|
$17.25
|
$4,497,214
|
-28.01% (-101,412)
|
-0%
|
|
2024 Q3
|
0.02%
|
362,120
|
$16.76
|
$6,069,129
|
+3.97% (+13,828)
|
+0%
|
|
2024 Q2
|
0.02%
|
348,292
|
$28.61
|
$9,964,641
|
-7.85% (-29,652)
|
-0%
|
|
2024 Q1
|
0.03%
|
377,944
|
$38.15
|
$14,418,551
|
+11.01% (+37,483)
|
+0%
|
|
2023 Q4
|
0.03%
|
340,461
|
$37.18
|
$12,658,339
|
-2.49% (-8,702)
|
-0%
|
|
2023 Q3
|
0.03%
|
349,163
|
$34.02
|
$11,878,542
|
+25.83% (+71,682)
|
+0.01%
|
|
2023 Q2
|
0.03%
|
277,481
|
$39.34
|
$10,916,111
|
-4.45% (-12,918)
|
-0%
|
|
2023 Q1
|
0.02%
|
$32.12
|
-1.25% (-3,676)
|
|||
|
2022 Q4
|
0.03%
|
$31.15
|
-12.90% (-43,566)
|
|||
|
2022 Q3
|
0.03%
|
$37.06
|
+9.10% (+28,171)
|
|||
|
2022 Q2
|
0.02%
|
$29.05
|
-15.99% (-58,889)
|
|||
|
2022 Q1
|
0.04%
|
$51.40
|
-4.54% (-17,520)
|
|||
|
2021 Q4
|
0.03%
|
$50.35
|
+25.32% (+77,968)
|
|||
|
2021 Q3
|
0.03%
|
$56.00
|
+28.65% (+68,571)
|
|||
|
2021 Q2
|
0.03%
|
$59.00
|
+7.91% (+17,535)
|
|||
|
2021 Q1
|
0.02%
|
$44.51
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.